A new two-phase initiative aims to streamline facility approvals, reduce reliance on foreign pharmaceutical production, and ...

As the gubernatorial election in Virginia heats up News 5 caught up with republican nominee Winsome Earle-Sears.

Gov. Glenn Youngkin was in Petersburg to celebrate progress on the third anniversary of his 'Partnership for Petersburg' ...

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.

Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

A panel of federal appeals judge ruled that four major drug makers acted similarly enough in substance and timing by restricting pharmaceutical subsidies and raising prices of certain popular diabetes ...

Tariffs would disrupt international supply chains, forcing companies to decide whether to pass on increased costs to patients ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...

Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a ...